A Day Up For Kala Pharmaceuticals, Inc.
Wed, Dec 28, 2022 at 07:05 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) soared at $12.48, a gain of 218.4%. On Wed, Dec 28, 2022, KALA:NASDAQ hit a New 2-Week High of $12.48. The stock appeared on our News Catalysts scanner on Wed, Dec 28, 2022 at 02:12 PM in the 'BIOTECH' category. From Wed, Dec 14, 2022, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Wed, Dec 28, 2022 at $17.48 with a volume of 50M+.
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 218.37%
- Minerva Surgical Inc. (UTRS:NASDAQ), 66.15%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 51.82%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 45.06%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 44.74%
- Gorilla Technology Group Inc. (GRRR:NASDAQ), 42.98%
- Nuwellis Inc. (NUWE:NASDAQ), 37.48%
- Argo Blockchain plc (ARBK:NASDAQ), 36.29%
- Unico American Corporation (UNAM:NASDAQ), 35.96%
- Jounce Therapeutics, Inc. (JNCE:NASDAQ), 33.79%